Good MorningIt was a game-changing week for equities last week. Fed chief Jerome Powell's commentary walloped the market that inflation was not tamed, rates would continue to rise, and peak interest rates may be higher than the market is forecasting. The news caused the market to sell off more than 200 points and create the largest red candle in months. The signal is that S&P 500 stocks are unlikely to move any higher this year and that downward risk is increasing. The last several candles like this led to further declines from 5% to 10%.
This week will be another hurdle for the market. The CPI data is due out on Tuesday and is expected to be hot. Another hot read of inflation data will keep the Fed on track to raise rates at least another 100 basis points; the next hike could be 50. The Fed needs to get the market's attention; its only weapon is interest rates. Featured: Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Vector Vest) 
|
Markets | | |
We're witnessing the second-largest bank failure in United States history as regulators shut down Silicon Valley Bank (NASDAQ: SIVB). Nobody has any idea what the implications are. Will regulators step in and make uninsured depositors whole?
The response from regulators is up in the air. The Fede... Read the Full Story |
|
From Our PartnersIf you’re looking for an INCREDIBLE deal on stocks with huge growth potential, now is the time to look at this list our team prepared.
(**By clicking the link you are subscribing to the Summa Money Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here)
| | Download The List With Details On Each Stock Here |
|
Markets | | | When European Union chief Ursula von der Leyen visited Britain last week, some joked on social media: Can you please bring us some tomatoes? People in the U.K. have had to ration salad staples like tomatoes and cucumbers for the past two weeks amid a shortage of fresh vegetables. Shelves of fresh pr... Read the Full Story |
|
Markets | | | Asian stock markets were mixed Thursday after signs of enduring upward pressure on American prices added to expectations of higher interest rates for longer.
Shanghai and Seoul advanced while Tokyo and Hong Kong declined. Oil prices edged higher.
Wall Street declined We... Read the Full Story |
|
|
Markets | | |
Investors who want exposure to real estate, but who don’t want to deal with clogged toilets, leaky roofs, and late rental payments often turn to real estate investment trusts, or REITs, which are reliable sources of income.
The largest publicly traded REIT, by market cap, is Prologis ... Read the Full Story |
|
Stocks | | |
Let's face it, 2022 was an ugly year for the stock market, with the NASDAQ 100 falling (32.58%) and the S&P 500 falling (18.17%). Individual stocks performed even worse. The two bright areas of performance were in the energy and healthcare sectors. Rising interest rates sent bond yields higher... Read the Full Story |
|
From Our PartnersSteve Cohen is known for making huge gains fast for investors...
But lately he's been building a billion-dollar stake in one little-known asset...
It's outpaced the S&P by 131% over the past 26 years & had a record 2022 while markets got crushed.
I'm talking about contemporary art...
The exclusive domain of the world's richest investors.
But a new investing platform called Masterworks is changing that. | | | | Click here to skip the waitlist and apply for membership now. |
|
Markets | | | Depositors withdrew savings and investors broadly sold off bank shares Monday as the federal government raced to reassure Americans that the banking system was secure after two bank failures fed fears that more financial institutions could fall.President Joe Biden insisted that the system was safe a... Read the Full Story |
|
Markets | | | Western sanctions have hit Russian banks, wealthy individuals and technology imports. But after a year of far-reaching restrictions aimed at degrading Moscow’s war chest, economic life for ordinary Russians doesn’t look all that different than it did before the invasion of Ukraine.There’s no mass un... Read the Full Story |
|
Markets | | | German Chancellor Olaf Scholz on Thursday called on China to refrain from sending weapons to Russia and instead use its influence to press Moscow for the withdrawal of Russian troops from Ukraine.“My message to Beijing is clear: use your influence in Moscow to press for the withdrawal of Russian tro... Read the Full Story |
|
Markets | | |
Investors who are looking for a break from market volatility are understandably concerned about the collapse of SVB Financial Group (NASDAQ: SIVB) the parent company of Silicon Valley Bank, on Friday, March 10. The instinct to push the panic button may be strong. But when it comes to your inv... Read the Full Story |
|
Markets | | |
Mortgage rates have risen to their highest levels in the past two decades, hovering at and above the 7% mark. The typical advice that mortgage lenders and real estate brokers give, and are doubling down on, during these challenging inflationary times is to 'Marry the house, date the rate'. However... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California. | | View Today's Stock Pick |
|
